Obesity is a major burden on healthcare systems worldwide. Recommendations in this patient group are severely lacking, so clinicians need to consider pharmacokinetic and pharmacodynamics parameters, and the relative risks of overdosing and underdosing. The attached document provides recommendations for how best to dose antimicrobials for the obese patient.
Questions? Page 970-GERM or the Antimicrobial Stewardship Evaluation Team (ASET) Pharmacist at 970-6666